Results 131 to 140 of about 4,927 (252)

Fluocinolone acetonide implant scleral fixation for cystoid macular edema in eyes with iris–lens diaphragm disruption

open access: yesThe Pan-American Journal of Ophthalmology
This is a two-center, case series of three patients with postoperative refractory cystoid macular edema (CME) and disruption of the iris–lens diaphragm, submitted to scleral fixation of fluocinolone acetonide implant. All patients achieved successful CME
Rita Costa Basto   +10 more
doaj   +1 more source

Bioavailability and activity of 0.1% amcinonide preparations: comparison with proprietary topical corticosteroid formulations of differing potencies [PDF]

open access: yes, 1979
The activity of a 0.1% amcinonide cream was compared with those of selected proprietary topical corticosteroid formulations of potencies differing according to the United Kingdom (U.K.) MIMS classification (very potent, potent and moderately potent ...
Haigh, J M, Woodford, R
core   +1 more source

Long-Term Control of Retinal Thickness Variability and Vision Following the 0.19 mg Fluocinolone Acetonide Implant. [PDF]

open access: yesJ Vitreoretin Dis, 2023
Sheth VS   +6 more
europepmc   +1 more source

Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries [PDF]

open access: hybrid, 2018
Usha Chakravarthy   +4 more
openalex   +1 more source

Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study

open access: yesClinical Ophthalmology
Ricardo Machado Soares,* Catarina Cunha Ferreira,* Joana da Silva Fernandes, Carolina Madeira, Luís MA Silva, Eduardo Saraiva, Lígia Ribeiro, Sofia Fonseca Department of Ophthalmology - Centro Hospitalar Vila Nova de Gaia e Espinho, Porto ...
Soares RM   +7 more
doaj  

Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study. [PDF]

open access: yesOphthalmol Ther, 2023
Rousseau N   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy